How Much Did Controlant Raise?
Funding & Key Investors

Controlant has secured significant capital, with total funding reaching $17.5M and a recent strategic investment of $15M. This major enterprise-level funding underscores the company's pivotal role in revolutionizing pharmaceutical supply chains through advanced digital solutions. The latest financing round, characterized as a major strategic investment, signals strong investor confidence in Controlant's vision and execution capabilities.

What is Controlant?

Controlant
SoftwareSupply Chain Management (SCM) Software

Controlant is a global leader in the digital transformation of pharmaceutical supply chains. The company's core mission is to achieve zero-waste supply chains for its partners and the planet by leveraging digitalization, automation, and transformation. This focus positions Controlant at the forefront of addressing critical industry challenges related to efficiency, sustainability, and product integrity within the highly regulated pharmaceutical sector. Their innovative approach aims to enhance visibility and control throughout the entire supply chain lifecycle.

How much funding has Controlant raised?

Controlant has raised a total of $17.5M across 2 funding rounds:

2016

Unspecified

$2.5M

2020

Series B

$15M

Unspecified (2016): $2.5M with participation from Frumtak Investment Fund

Series B (2020): $15M, investors not publicly disclosed

Key Investors in Controlant

Frumtak Investment Fund

Frumtak Ventures is an early-stage venture capital fund based in Iceland that invests in local innovation with global potential. The firm focuses on supporting founders who have shown early traction and the capability for international growth. They take a high-conviction and high-involvement approach to investing, collaborating with portfolio companies from seed stage through IPO, with initial investments typically ranging from 1 million to 3 million. Their target clients are innovative startups looking for strategic partnerships and funding to scale their businesses.

What's next for Controlant?

With this substantial enterprise-level funding, Controlant is poised for accelerated growth and further innovation. The strategic investment is expected to fuel the expansion of its digital platform, enhance its global operational capabilities, and deepen its market penetration. Controlant's trajectory suggests a continued focus on scaling its solutions to meet the increasing demand for resilient and transparent pharmaceutical supply chains. Future developments will likely involve further integration of advanced technologies and strategic partnerships to solidify its leadership position.

See full Controlant company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftware
Engineering SoftwareSoftwareMobile App Development
Multimedia, Games & Graphics SoftwareSoftware
Engineering SoftwareSoftwareNetworking Software

Frequently Asked Questions Regarding Controlant Financial Insights

What are the most recent funding rounds that Controlant has completed, and what were the funding rounds?
Controlant has recently completed 2 funding rounds: Series B on Sep 30, 2020, Unspecified on Jan 17, 2016.
What is the total amount of funding Controlant has raised to date?
Controlant has raised a total of $17.5M in funding to date.
How many funding rounds has Controlant completed?
Controlant has completed 2 funding rounds.
How much funding did Controlant raise in its most recent funding round?
Controlant raised $15M in its most recent funding round.
Which was the largest funding round in Controlant's history?
The largest funding round in Controlant's history was $15M.
See more information about Controlant